Navigation Links
Global Hemoglobin A1c Testing Devices (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay) Market - Forecast to 2019
Date:8/6/2014

DUBLIN, Aug. 6, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient's blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test.

Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.

Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview

Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use

Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology

Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography

Chapter 7 Recommendations

Chapter 8 Company Profiles

Companies Mentioned:

  • ARKRAY
  • Abbott
  • Alere
  • Bio-Rad
  • Chek Diagnostics
  • Danaher Corporation
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Menarini
  • Sebia
  • Siemens
  • Tosoh
  • Trinity Biotech

For more information visit http://www.researchandmarkets.com/research/3s8sxj/hemoglobin_a1c

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Safety Syringes (Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes, Non-Retractable Safety Syringes) Market - Forecast to 2019
2. Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral Feeding Pumps, Administration Reservoir, Giving Sets and Enteral Syringes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
3. Orthopedic Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
4. Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Global Digital X-ray (Floor to ceiling mounted, Ceiling mounted, Handheld) Market - Forecast to 2018
6. Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting
7. Myalgia Global Clinical Trials Review, H2, 2014
8. Myoclonus Global Clinical Trials Review, H2, 2014
9. Neuralgia Global Clinical Trials Review, H2, 2014
10. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
11. Muscle Spasticity Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):